The clinical study results establish Zestra as the only non-prescription womens' product which has
demonstrated robust increases in female sexual pleasure in well-controlled clinical studies
conducted by independent sexual medicine experts.
Zestra has been under scientific development by pharmaceutical scientists for more than 5 years and is NOT to be confused with any of those "novelty-type" products on the market which produce sensation through skin irritation. Zestra is the clinically tested women's topical product that is recommended by sexual health professionals.
1. RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND, CROSSOVER DESIGN PILOT TRIAL OF THE EFFICACY AND SAFETY OF ZESTRA™ FOR WOMEN IN WOMEN WITH, AND WITHOUT, FSAD.
>> view clinical study
>> view slide
presentation
2. THE EFFECT OF ANTIDEPRESSANT USAGE ON THE EFFICACY OF ZESTRA™ FOR WOMEN IN WOMEN WITH, AND WITHOUT, FSAD.
>> view clinical study
>> View
slide presentation
Market Research
This report presents the findings of qualitative research conducted by Global Healthcare Associates on behalf of QualiLife Pharmaceuticals, Inc.
(Women's Consumer Product Division) for the purpose of gaining a well-rounded understanding of female sexual health, pleasure, and satisfaction market
opportunity. View the complete Zestra Market Research Results (PDF).
Initial Consumer Testing
Preliminary safety and efficacy of Zestra™ for Women in premenopausal and postmenopausal normal women interested in increasing sexual pleasure, and women with self-described sexual
difficulties or decreased sexual pleasure. view the
consumer testing
